Shogo Nomura

Project Lecturer

University of Tokyo

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Shogo Nomura is a Project Lecturer at the University of Tokyo, Japan. His research primarily focuses on clinical studies involving cancer treatment methodologies, including investigations on EGFR Tyrosine Kinase Inhibitors and various chemotherapy combinations in non-small cell lung cancer. He has contributed to significant multicenter trials assessing novel therapies for colorectal cancer and the use of advanced imaging techniques in surgical outcomes.

Articles (12)

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

JAPAN

View details

Yoshito Komatsu

Hokkaido University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shogo Nomura

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non–Small Cell Lung Cancer Harboring EGFR Mutation

Adjustment of Conditional Bias in Hazard Ratios for Group Sequential Testing of Progression‐Free Survival and Overall Survival

Comment on “Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment”

A Multicenter, Randomized Phase III Study Comparing Platinum Combination Chemotherapy Plus Pembrolizumab With Platinum Combination Chemotherapy Plus Nivolumab and Ipilimumab for Treatment-Naive Advanced Non–Small Cell Lung Cancer Without Driver Gene Alterations: JCOG2007 (NIPPON Study)

Multicenter Phase I/II Trial of Napabucasin and Pembrolizumab in Patients with Metastatic Colorectal Cancer (EPOC1503/SCOOP Trial)

A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck

BIG BANG study (EPOC1703): Multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer

Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local therapies for elderly, vulnerable patients

Comparison of Carboplatin plus Pemetrexed Followed by Maintenance Pemetrexed with Docetaxel Monotherapy in Elderly Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial

Impact of intraoperative indocyanine green fluorescence angiography on anastomotic leakage after laparoscopic sphincter-sparing surgery for malignant rectal tumors

Optimal method for measuring invasive size that predicts survival in invasive mucinous adenocarcinoma of the lung

Performance of randomization-based causal methods with and without integrating external data sources for adjusting overall survival in case of extensive treatment switches in placebo-controlled randomized oncology phase 3 trials

Collaborators (6)

Kentaro Tanaka

Yutaka Fujiwara

Yukari Uemura

Eiji Iwama

Satoshi Yuki

Yoshito Komatsu

Make your next move.